Literature DB >> 17434543

Hypoglycemia activates arousal-related neurons and increases wake time in adult rats.

Nancy C Tkacs1, Yanhua Pan, Gagan Sawhney, Graziella L Mann, Adrian R Morrison.   

Abstract

Hypoglycemia resulting from excess of exogenous or endogenous insulin elicits central nervous system activation that contributes to counterregulatory hormone secretion. In adult humans without diabetes, hypoglycemia occurring during sleep usually produces cortical activation with awakening. However, in adult humans with type 1 diabetes, hypoglycemic arousal appears blunted or absent. We hypothesized that insulin injection sufficient to produce hypoglycemia would induce awakening in adult male rats. Polysomnographic studies were carried out to characterize the effect of insulin injection on measures of sleep and waking during a circadian time of increased sleep. Compared to a baseline day, insulin treatment more than doubled the time spent awake, from 18.4+/-2.6% after saline injection to 48.0+/-5.5% after insulin. Insulin injection also reduced rapid eye movement sleep (REMS) from 27.3+/-1.8% to 5.6+/-1.3%. The percent of time in non-REM sleep (NREMS) sleep was not different between saline and insulin days, however, NREMS after insulin was fragmented, with increased number and decreased duration of episodes. These electrophysiological data indicate that insulin-induced hypoglycemia is an arousing stimulus in rats, as in nondiabetic adult humans. We also studied the effect of insulin on activation of selected arousal-related neurons using immunohistochemical detection of Fos. Fos-immunoreactivity increased in orexin (OX) neurons after insulin, from 8.7+/-4.9% after saline injection to 37+/-9% after insulin. Basal forebrain cholinergic nuclei also showed increased Fos-immunoreactivity after insulin. These correlated behavioral and histological data provide targets for future studies of the neural pathways underlying hypoglycemic arousal.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17434543      PMCID: PMC1934507          DOI: 10.1016/j.physbeh.2007.03.003

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  46 in total

1.  Noradrenergic and GABAergic systems in the medial hypothalamus are activated during hypoglycemia.

Authors:  J L Beverly; M G De Vries; S D Bouman; L M Arseneau
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-02       Impact factor: 3.619

2.  Hypocretin-1 modulates rapid eye movement sleep through activation of locus coeruleus neurons.

Authors:  P Bourgin; S Huitrón-Résendiz; A D Spier; V Fabre; B Morte; J R Criado; J G Sutcliffe; S J Henriksen; L de Lecea
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

3.  PVN activation is suppressed by repeated hypoglycemia but not antecedent corticosterone in the rat.

Authors:  S B Evans; C W Wilkinson; K Bentson; P Gronbeck; A Zavosh; D P Figlewicz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2001-11       Impact factor: 3.619

4.  Localization of glucokinase gene expression in the rat brain.

Authors:  R M Lynch; L S Tompkins; H L Brooks; A A Dunn-Meynell; B E Levin
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

5.  Presumed apoptosis and reduced arcuate nucleus neuropeptide Y and pro-opiomelanocortin mRNA in non-coma hypoglycemia.

Authors:  N C Tkacs; A A Dunn-Meynell; B E Levin
Journal:  Diabetes       Date:  2000-05       Impact factor: 9.461

6.  Fos expression in orexin neurons varies with behavioral state.

Authors:  I V Estabrooke; M T McCarthy; E Ko; T C Chou; R M Chemelli; M Yanagisawa; C B Saper; T E Scammell
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Hypoglycemia activates orexin neurons and selectively increases hypothalamic orexin-B levels: responses inhibited by feeding and possibly mediated by the nucleus of the solitary tract.

Authors:  X J Cai; M L Evans; C A Lister; R A Leslie; J R Arch; S Wilson; G Williams
Journal:  Diabetes       Date:  2001-01       Impact factor: 9.461

8.  The rat as an experimental model for sleep neurophysiology.

Authors:  S Datta; J A Hobson
Journal:  Behav Neurosci       Date:  2000-12       Impact factor: 1.912

9.  A comparison of two immediate-early genes, c-fos and NGFI-B, as markers for functional activation in stress-related neuroendocrine circuitry.

Authors:  R K Chan; E R Brown; A Ericsson; K J Kovács; P E Sawchenko
Journal:  J Neurosci       Date:  1993-12       Impact factor: 6.167

10.  The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats.

Authors:  D C Piper; N Upton; M I Smith; A J Hunter
Journal:  Eur J Neurosci       Date:  2000-02       Impact factor: 3.386

View more
  6 in total

1.  Nocturnal hypoglycaemia presenting as somnambulism.

Authors:  D S H Bell
Journal:  Diabetologia       Date:  2010-06-29       Impact factor: 10.122

2.  Expression of the diabetes-associated gene TCF7L2 in adult mouse brain.

Authors:  Syann Lee; Charlotte E Lee; Carol F Elias; Joel K Elmquist
Journal:  J Comp Neurol       Date:  2009-12-20       Impact factor: 3.215

3.  Insulinoma presenting as idiopathic hypersomnia.

Authors:  Michelangelo Maestri; Fabio Monzani; Enrica Bonanni; Elisa Di Coscio; Fabio Cignoni; Angela Dardano; Alfonso Iudice; Luigi Murri
Journal:  Neurol Sci       Date:  2010-01-30       Impact factor: 3.307

Review 4.  Pathophysiology of Migraine: A Disorder of Sensory Processing.

Authors:  Peter J Goadsby; Philip R Holland; Margarida Martins-Oliveira; Jan Hoffmann; Christoph Schankin; Simon Akerman
Journal:  Physiol Rev       Date:  2017-04       Impact factor: 37.312

Review 5.  Neural pathways that control the glucose counterregulatory response.

Authors:  Anthony J M Verberne; Azadeh Sabetghadam; Willian S Korim
Journal:  Front Neurosci       Date:  2014-02-26       Impact factor: 4.677

Review 6.  The Interaction Between Sleep and Metabolism in Alzheimer's Disease: Cause or Consequence of Disease?

Authors:  Caitlin M Carroll; Shannon L Macauley
Journal:  Front Aging Neurosci       Date:  2019-09-20       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.